Literature DB >> 27189357

Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years.

John Bian1, Charles Bennett2, Gregory Cooper2, Alessandra D'Alfonso2, Deborah Fisher2, Joseph Lipscomb2, Chao-Nan Qian2.   

Abstract

INTRODUCTION: There are concerns about potential overuse of colorectal cancer (CRC) screening services among average-risk individuals older than age 75 years.
MATERIALS AND METHODS: Using a 5% random noncancer sample of Medicare beneficiaries who resided in the SEER areas, we examined rates of CRC screening adherence, defined by the Medicare coverage policy, among average-risk fee-for-service beneficiaries age 76 to 95 years from 2002 to 2010. The two outcomes are the status of overall CRC screening adherence, and the status of adherence to colonoscopy (v other modalities) conditional on patient adherence.
RESULTS: Overall CRC screening adherence rates of Medicare beneficiaries age 76 to 95 years increased from 13.0% to 21.4% from 2002 to 2010. In 2002, 2.2% of beneficiaries were adherent to colonoscopy, and 10.7%, by other modalities; the corresponding rates were 19.5% and 1.9%, respectively, in 2010. Specifically, rates of adherence to colonoscopy were 1.1% for those age 86 to 90 years and almost nil for those age 91 to 95 years in 2002, but the rates became 13.5% and 8.2%, respectively, in 2010. Compared with white beneficiaries, black beneficiaries age 76 to 95 years had a 7-percentage-point lower adherence rate. However, overall adherence rates among blacks increased by 168.6% from 2002 to 2010, whereas rates among whites increased by 63.0%. Logistic regressions showed that blacks age 86 to 95 years were less likely than whites to be adherent (odds ratio, 0.56; 95% CI, 0.47 to 0.59) but were more likely to be adherent to colonoscopy (odds ratio, 2.34; 95% CI, 1.47 to 3.91).
CONCLUSION: High proportions of average-risk Medicare fee-for-service beneficiaries screened by colonoscopy may represent opportunities for improving appropriateness and allocative efficiency of CRC screening by Medicare.
Copyright © 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2016        PMID: 27189357      PMCID: PMC5946705          DOI: 10.1200/JOP.2015.009118

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  31 in total

1.  Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly?

Authors:  Ya-Chen Tina Shih; Lirong Zhao; Linda S Elting
Journal:  Health Aff (Millwood)       Date:  2006 Jul-Aug       Impact factor: 6.301

2.  Trends in colonoscopy for colorectal cancer screening.

Authors:  Kathryn A Phillips; Su-Ying Liang; Uri Ladabaum; Jennifer Haas; Karla Kerlikowske; David Lieberman; Robert Hiatt; Mika Nagamine; Stephanie L Van Bebber
Journal:  Med Care       Date:  2007-02       Impact factor: 2.983

3.  Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.

Authors:  Judith Swan; Nancy Breen; Ralph J Coates; Barbara K Rimer; Nancy C Lee
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Authors:  Eric A Engels; Ruth M Pfeiffer; Winnie Ricker; William Wheeler; Ruth Parsons; Joan L Warren
Journal:  Am J Epidemiol       Date:  2011-08-04       Impact factor: 4.897

5.  Overuse of screening colonoscopy in the Medicare population.

Authors:  James S Goodwin; Amanpal Singh; Nischita Reddy; Taylor S Riall; Yong-Fang Kuo
Journal:  Arch Intern Med       Date:  2011-05-09

6.  Colorectal cancer screening among African-American and white male veterans.

Authors:  Nancy C Dolan; M Rosario Ferreira; Marian L Fitzgibbon; Terry C Davis; Alfred W Rademaker; Dachao Liu; June Lee; Michael Wolf; Brian P Schmitt; Charles L Bennett
Journal:  Am J Prev Med       Date:  2005-06       Impact factor: 5.043

7.  Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees.

Authors:  Thomas J Semrad; Daniel J Tancredi; Laura-Mae Baldwin; Pamela Green; Joshua J Fenton
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

Review 8.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

9.  Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure.

Authors:  Louise C Walter; Natalie P Davidowitz; Paul A Heineken; Kenneth E Covinsky
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

10.  Rates and predictors of colorectal cancer screening.

Authors:  Su-Ying Liang; Kathryn A Phillips; Mika Nagamine; Uri Ladabaum; Jennifer S Haas
Journal:  Prev Chronic Dis       Date:  2006-09-15       Impact factor: 2.830

View more
  7 in total

1.  Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.

Authors:  John Bian; Brian Chen; Dawn L Hershman; Norman Marks; LeAnn Norris; Richard Schulz; Charles L Bennett
Journal:  J Clin Oncol       Date:  2017-04-25       Impact factor: 44.544

2.  Decreasing Black-White Disparities in Colorectal Cancer Incidence and Stage at Presentation in the United States.

Authors:  Folasade P May; Beth A Glenn; Catherine M Crespi; Ninez Ponce; Brennan M R Spiegel; Roshan Bastani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-29       Impact factor: 4.254

3.  Overuse of colorectal cancer screening services in the United States and its implications.

Authors:  John Bian
Journal:  Chin J Cancer       Date:  2016-09-15

4.  Assessing the impact of colonoscopy complications on use of colonoscopy among primary care physicians and other connected physicians: an observational study of older Americans.

Authors:  Nancy L Keating; A James O'Malley; Jukka-Pekka Onnela; Bruce E Landon
Journal:  BMJ Open       Date:  2017-06-23       Impact factor: 2.692

5.  Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data.

Authors:  David B Preen; Iris Lansdorp-Vogelaar; Hooi C Ee; Cameron Platell; Dayna R Cenin; Lakkhina Troeung; Max Bulsara; Peter O'Leary
Journal:  Front Public Health       Date:  2017-09-08

6.  Does self-reported symptom questionnaire play a role in nonadherence to colonoscopy for risk-increased population in the Tianjin colorectal cancer screening programme?

Authors:  Lizhong Zhao; Xiaorui Zhang; Yongjie Chen; Yuan Wang; Weihua Zhang; Wenli Lu
Journal:  BMC Gastroenterol       Date:  2021-03-09       Impact factor: 3.067

7.  Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66-75 years in 2016-2018.

Authors:  Suying Li; Lesley-Ann Miller-Wilson; Haifeng Guo; Madison Hoover; Deborah A Fisher
Journal:  BMC Health Serv Res       Date:  2022-10-03       Impact factor: 2.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.